Mayne Pharma Group Financial Overview
Mayne Pharma Group's market cap is currently $170.05M. The company's EPS TTM is $-0.561186685; its P/E ratio is -3.18; Mayne Pharma Group is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
